RECURSION PHARMACEUTICALS, INC. ($RXRX)
Filing Information
| Accession Number | 0001601830-26-000021 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 20, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
147,265
Total Value
$233,554.85
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Class A Common Stock | โ | Feb 17, 2026 | Tax Withholding | 27,265 | $3.49 | $95,154.85 | 906,556 | Direct | โ | View Details | |
Director | Class A Common Stock | โ | Feb 19, 2026 | Conversion | 40,000 | $0.00 | $0.00 | 946,556 | Direct | โ | View Details | |
Director | Class A Common Stock | โ | Feb 19, 2026 | Sale | 40,000 | $3.46 | $138,400.00 | 906,556 | Direct | โ | View Details | |
Director | Class B Common Stock | Derivative | Feb 19, 2026 | Conversion | 40,000 | $0.00 | $0.00 | 4,543,334 | Direct | โ | View Details |